Repeat administration of high dose melphalan in relapsed myeloma.

At a median time of 20 months following high dose melphalan for myeloma, 29 patients relapsed and were treated with induction chemotherapy to maximum response followed by a second course of high dose melphalan. The majority (90%) of patients received 200 mg m-2 with an autologous bone marrow transpl...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Mansi, J. L., Cunningham, D., Viner, C., Ellis, E., Meldrum, M., Milan, S., Gore, M.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1993
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968739/
https://ncbi.nlm.nih.gov/pubmed/8217614
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items